BioStem Technologies, Inc. (BSEM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Previous Close | 3.68 |
| Open | 3.69 |
| Day High | 3.69 |
| Day Low | 3.53 |
| 52-Week High | 8.4 |
| 52-Week Low | 2.25 |
| Volume | 63,391 |
| Average Volume | 68,587 |
| Market Cap | 60.12M |
| PE | -3.37 |
| EPS | -1.05 |
| Moving Average 50 Days | 3.6 |
| Moving Average 200 Days | 4.47 |
| Change | -0.14 |
BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026
GlobeNewswire Inc.
Mar 11, 2026 8:05 PM GMT
Conference call and webcast to be held at 4:30 PM ETPOMPANO BEACH, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinat
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
GlobeNewswire Inc.
Feb 20, 2026 12:00 PM GMT
POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care,
BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research
GlobeNewswire Inc.
Feb 03, 2026 9:05 PM GMT
POMPANO BEACH, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care,